Toxicity of tirapazamine, cisplatin and fluorouracil as induction chemotherapy and simultaneous chemoradiotherapy for organ preservation in head and neck cancer.

被引：0
|
作者：
Pinto, HA
Le, Q
Terris, DJ
Goffinet, DR
Brown, JM
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
312
引用
收藏
页码：4527S / 4528S
页数：2
相关论文
共 50 条
  • [1] Toxicity of induction chemotherapy with docetaxel, cisplatin, & 5-fluorouracil for advanced head and neck cancer
    Billan, Salem
    Kaidar-Person, Orit
    Atrash, Fadi
    Doweck, Ilana
    Haim, Nissim
    Kuten, Abraham
    Ronen, Ohad
    TUMOR BIOLOGY, 2012, 33 : 77 - 78
  • [2] Toxicity of Induction Chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil for Advanced Head and Neck Cancer
    Billan, Salem
    Kaidar-Person, Orit
    Atrash, Fadi
    Doweck, Ilana
    Haim, Nissim
    Kuten, Abraham
    Ronen, Ohad
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (05): : 231 - 235
  • [3] Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: Long-term follow-up
    Psyrri, A
    Kwong, M
    DiStasio, S
    Lekakis, L
    Kassar, M
    Sasaki, C
    Wilson, LD
    Haffty, BG
    Son, YH
    Ross, DA
    Weinberger, PM
    Chung, GG
    Zelterman, D
    Burtness, BA
    Cooper, DL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3061 - 3069
  • [4] Concomitant chemoradiotherapy alone or with induction chemotherapy in advanced head and neck cancer.
    Teixeira, R.
    Cavaleiro, A.
    Vieira, P.
    Aveiro, F.
    Vieira, G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 36 - 36
  • [5] Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer
    Hitt, R
    López-Pousa, A
    Martínez-Trufero, J
    Escrig, V
    Carles, J
    Rizo, A
    Isla, D
    Vega, ME
    Martí, JL
    Lobo, F
    Pastor, P
    Valentí, V
    Belón, J
    Sánchez, MA
    Chaib, C
    Pallarés, C
    Antón, A
    Cervantes, A
    Paz-Ares, L
    Cortés-Funes, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8636 - 8645
  • [6] Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer:: Clinical outcome, toxicity and organ/function preservation
    Mantovani, G
    Macciò, A
    Mulas, C
    Massa, E
    Mudu, MC
    Massidda, S
    Massa, D
    Murgia, V
    Ferreli, L
    Astara, G
    Proto, E
    Tore, G
    Mura, M
    Amichetti, M
    TUMORI, 2001, 87 (04) : S43 - S44
  • [7] Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer:: Clinical outcome, toxicity and organ/function preservation
    Mantovani, G
    Macciò, A
    Massa, E
    Mulas, C
    Mudu, MC
    Massidda, S
    Massa, D
    Murgia, V
    Ferreli, L
    Succu, G
    Astara, G
    Proto, E
    Tore, G
    Mura, M
    Maxia, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (06) : 1227 - 1233
  • [8] Concurrent chemoradiotherapy with or without induction chemotherapy for locally advanced head and neck cancer.
    Caudell, J. J.
    Spencer, S.
    Meredith, R.
    Nabell, L.
    Bonner, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Another look at induction chemotherapy for organ preservation in patients with head and neck cancer
    Forastiere, AA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (13) : 855 - 856
  • [10] Induction combination chemotherapy with gemcitabine and cisplatin in locally advanced head and neck cancer.
    Shehzad, K.
    Jamshed, A.
    Hussain, R.
    Muhammad, B.
    Azhar, R.
    Shah, M.
    Hameed, S.
    Farooqi, Z.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S344 - S344
12345